Keep the competitive advantage in your market and develop a guideline to expanding your business in the CEE & CIS
There is a significant pressure on the industry to instant changes - like mitigating operational costs, lowering prices, meeting regulatory standards, sustaining global growth, just to name but a few. While pharma companies need to strive for commercializing drugs with maximized efficiency and minimized side effects, they also need to find out how they can overcome the challenges of successful cooperation with the local governments, parallel trade and EU regulations. Moreover, the CEE & CIS regions are constantly changing business environments.
This event has therefore the aim to offer a discussion platform for exchanging experiences on the possibilities and strategies for market entry and local progress. This year, the 5th Annual CEE & CIS Pharmaceutical Challenges conference gives participants the insight into the crucial factors in pricing and reimbursement strategies as the basis of successful sales and marketing approaches in the region. Furthermore, delegates will have the opportunity to meet the representatives of local regulatory bodies, get first hand information, and explore the potentials in the various countries.
Join and meet senior executives from Pfizer, Dr. Reddy’s Laboratories, Pliva Barr Group, Boehringer-Ingelheim, Polpharma Group, AstraZeneca, and many others from the forefront of their fields. Find out how they can maintain and increase their market share in the rapidly changing environment of the region!As in the past four consecutive years, the 2-day discussion forum is expected to be once again the major forum of strategic decision makers of the CEE & CIS pharmaceutical market.
For more information about this event and Jacob Fleming Conferences, contact Kriszta Nagy at +421 257 272 131 or via email
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
In collaboration with Regulanet network of regulatory affairs consultants throughout Europe and USA, we keep
daily contacts and communication with National Agencies for Medicines
and Medical Devices. Beside regulatory we also maintain understanding of the business, scientific and technical background of products.